Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:AYA
TSX:AYAMetals and Mining

Assessing Aya Gold & Silver’s Valuation As Zgounder Financing Closes And Production And Resources Advance

Aya Gold & Silver (TSX:AYA) is back in focus after securing financial completion on its US$100 million EBRD loan for the Zgounder expansion, alongside record 2025 production and substantial reserve and resource updates. See our latest analysis for Aya Gold & Silver. The financial completion of the EBRD loan and record 2025 production sit alongside a sharp acceleration in Aya’s recent share price, with a 30 day share price return of 36.38% and a 90 day share price return of 92.93%. The 1 year...
NYSE:SHW
NYSE:SHWChemicals

Assessing Sherwin-Williams (SHW) Valuation After Recent Share Price Moves

Why Sherwin-Williams Is On Investors’ Radar Today Sherwin-Williams (SHW) is drawing fresh attention after recent share price moves, with the stock closing at $348.52 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for Sherwin-Williams. For context, Sherwin-Williams’ 30-day share price return of 7.09% and year-to-date share price return of 6.31% sit against a 1-year total shareholder return decline of 2.37%. At the same time, 3-year and 5-year...
NasdaqGS:BHF
NasdaqGS:BHFInsurance

Assessing Brighthouse Financial (BHF) Valuation After Strong 3 Month And 1 Year Returns

Why Brighthouse Financial is on investor watchlists Brighthouse Financial (BHF) has drawn attention after a strong past 3 months total return of about 37%, alongside a 1 year total return near 26%. This performance is prompting fresh questions about what is already reflected in the share price. See our latest analysis for Brighthouse Financial. That recent 36.96% 90 day share price return contrasts with a small year to date share price decline, while the 1 year total shareholder return of...
TSE:8593
TSE:8593Diversified Financial

What Mitsubishi HC Capital (TSE:8593)'s Space BD Alliance Means For Shareholders

Mitsubishi HC Capital Inc. recently entered into a capital and business alliance with Space BD Inc., becoming the lead investor in Space BD's Series C round to jointly create new space-related service models and expand business opportunities. A distinctive feature of this alliance is Mitsubishi HC Capital’s plan to combine its asset-ownership and financing capabilities with Space BD’s industry-government-academia network to influence space-sector rulemaking and market development. With this...
TSXV:AMRQ
TSXV:AMRQMetals and Mining

Amaroq (TSXV:AMRQ) Is Up 20.2% After Defining 80 km High-Grade IOCG Iron System in Greenland

In January 2026, Amaroq Ltd. reported significant 2025 exploration results from its Minturn prospect in Northwest Greenland, outlining an 80 km mineralised IOCG-style system with surface iron grades reaching up to 69.5% Fe and a 9 km magnetite-rich trend. The identification of what appears to be a Kiruna-style IOCG system with potential for direct shipping ore for direct reduced iron products adds a new critical minerals dimension to Amaroq’s Greenland portfolio beyond its historic gold...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

A Look At Zions Bancorporation (ZION) Valuation After Its Strong Fourth Quarter Earnings Beat

Zions Bancorporation National Association (ZION) drew investor attention after fourth quarter 2025 results exceeded earnings and revenue expectations, with shares rising 2.7% in the afternoon session following the announcement. See our latest analysis for Zions Bancorporation National Association. That earnings beat comes after a mixed stretch for the stock, with an 11.79% 90 day share price return, a 4.18% 1 year total shareholder return and a 58.76% 5 year total shareholder return. This...
NasdaqGS:ENVX
NasdaqGS:ENVXElectrical

Is Enovix (ENVX) Now An Opportunity After Recent Share Price Weakness?

If you are wondering whether Enovix at around US$7.53 is starting to look interesting, you are not alone. The key question is how that price stacks up against what the business might be worth. The share price has seen a 8.6% decline over the last week, a 1.3% decline over the last month, and is down 4.6% year to date and 38.9% over the past year, which will shape how you think about both upside potential and risk. Alongside these moves, recent company updates and industry headlines around...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

Did FDA Alignment on BEAM-302’s Accelerated Pathway Just Shift Beam Therapeutics' (BEAM) Investment Narrative?

Recently, analysts at Bernstein and J.P. Morgan highlighted Beam Therapeutics’ progress after the company secured FDA alignment on an accelerated approval pathway for its BEAM-302 gene-editing program targeting Alpha-1 Antitrypsin Deficiency. This regulatory clarity is being interpreted as a meaningful de-risking of BEAM-302 and a potential catalyst for broader pharmaceutical interest in Beam’s base-editing platform. Next, we’ll examine how this clearer accelerated approval pathway for...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy Reshapes Growth, Income Profile With LS Power Deal And CEO Shift

NRG Energy (NYSE:NRG) agreed to acquire LS Power for $12b, which would significantly expand its natural gas generation portfolio. The company announced a planned CEO succession alongside the LS Power deal, signaling an upcoming leadership handoff. NRG approved an 8% dividend increase, extending a six year streak of dividend growth. The company also entered a partnership with Sunrun to expand home battery storage and virtual power plants in Texas. NRG Energy comes into these changes with its...
NasdaqGS:FITB
NasdaqGS:FITBBanks

Fifth Third Weighs Credit Leadership Shift As Comerica Merger Nears Completion

Fifth Third Bancorp (NasdaqGS:FITB) has announced a planned retirement and succession for its long-serving chief credit officer, marking a significant transition in its credit organization. The company has also received all necessary regulatory and shareholder approvals to complete its merger with Comerica. These two developments were announced together, signaling a period of leadership change and expansion for the bank. Fifth Third Bancorp, a regional banking group, operates across retail,...
NYSE:ABM
NYSE:ABMCommercial Services

Is It Time To Reconsider ABM Industries (ABM) After Recent Share Price Weakness?

If you are wondering whether ABM Industries is a bargain or fairly priced at around US$45.37, you are not alone. This article focuses squarely on what the current share price might imply about value. The stock has returned 0.2% over the last 7 days and 6.3% over the last 30 days and year to date, although the 1 year return sits at an 11.8% decline and the 5 year return stands at 36.2%. Recent attention on ABM Industries has centered on its role as a facilities services provider across...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Are AI-Driven Short Bets on Cellebrite (CLBT) Revealing a Deeper Shift in Its Investment Story?

Cellebrite DI, a provider of digital investigative solutions, recently drew attention as institutional AI-driven trading models highlighted weak sentiment across all timeframes and promoted short-oriented trading strategies in its shares. Rather than a single company announcement, the focus on an unusually strong risk‑reward profile for short sellers appears to be shaping how market participants and analysts are reassessing Cellebrite DI’s prospects. We’ll now explore how the AI-driven...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

How AI‑Enabled Antibody Discovery Market Growth Positioning At Twist Bioscience (TWST) Has Changed Its Investment Story

Recent research highlighted that the global antibody discovery market is expected to reach about US$35.35 billion by 2035, driven by advances in engineering technologies, automation, and artificial intelligence, with Twist Bioscience identified as one of the key industry participants. This positions Twist Bioscience at the center of a rapidly evolving field where AI-enabled, high-throughput discovery platforms are becoming increasingly important for precision therapies. We’ll now examine how...
NYSE:G
NYSE:GProfessional Services

Will Genpact’s (G) New AI-First Accolades and Brand Momentum Reshape Its Investment Narrative?

In recent months, Genpact has been named a Leader in Everest Group's 2025 Banking Operations PEAK Matrix® and climbed in Brand Finance’s 2026 IT Services 25 ranking, reflecting its pivot to AI-first, technology-led solutions and a global rebrand launched in 2025. Together, these independent endorsements highlight how Genpact’s focus on agentic AI, modular digital platforms, and domain expertise is strengthening its position with global banking and IT services clients. Next, we’ll examine how...
NYSE:LCII
NYSE:LCIIAuto Components

LCI Industries (LCII) Valuation Check After Strong Q3 Results And Optimistic 2025 Outlook

Third quarter results and outlook for 2025 LCI Industries (LCII) reported strong third quarter results, driven by its OEM segment, higher North American sales, and acquisitions, alongside a positive 2025 outlook for operating margins, revenues, and earnings that has drawn fresh investor attention. See our latest analysis for LCI Industries. The strong quarterly update has arrived alongside powerful recent momentum in the shares, with a 90 day share price return of 59.87% and a 1 year total...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And Merck Oncology Partnership

Guardant Health (GH) is back in focus after the U.S. Food and Drug Administration approved its Guardant360 CDx test for use in BRAF V600E-mutant metastatic colorectal cancer, along with a new collaboration with Merck in oncology. See our latest analysis for Guardant Health. Guardant Health’s 90 day share price return of 61.96% and 30 day share price return of 11.43% suggest strong positive momentum, while the 1 year total shareholder return of 143.06% points to significant gains for longer...
NasdaqGS:CHKP
NasdaqGS:CHKPSoftware

AI-Powered Exposure Management Launch Could Be A Game Changer For Check Point Software Technologies (CHKP)

Earlier this week, Check Point Software Technologies launched Check Point Exposure Management, an AI-driven platform that unifies threat intelligence, attack-surface visibility, exploitability context, and automated remediation across integrations with more than 75 security controls from about 90% of the largest security vendors. The launch aligns directly with Gartner’s Continuous Threat Exposure Management framework, underscoring Check Point’s push to turn fragmented security data into...
NasdaqCM:RCAT
NasdaqCM:RCATAerospace & Defense

Red Cat’s Revenue Surge Tests Durability Of Defense Drone Opportunity

Red Cat Holdings (NasdaqCM:RCAT) preannounced Q4 sales that point to a sharp jump in revenue tied to its domestically manufactured drones. The company is highlighting expansion opportunities as U.S. regulations restrict foreign-made drones in sensitive use cases. Recent partnerships with Palantir and Safe Pro are aimed at broadening Red Cat's role within defense and government drone programs. Heightened geopolitical tensions are contributing to stronger demand signals from defense buyers for...
NYSE:TXT
NYSE:TXTAerospace & Defense

Is Textron (TXT) Offering Value After Strong Multi Year Share Price Gains

If you are wondering whether Textron's current share price reflects its true worth, you are not alone. This article is built to help you size up that question clearly. Textron shares recently closed at US$95.00, with returns of 0.8% over 7 days, 5.3% over 30 days, 9.1% year to date, 23.2% over 1 year and 31.8% over 3 years, while the 5 year return sits at 111.0%. These price moves sit against a backdrop of ongoing market interest in Textron as an industrial and aerospace group. Investors are...
NYSE:MTZ
NYSE:MTZConstruction

Is It Too Late To Consider MasTec (MTZ) After A 51% One Year Surge?

If you are wondering whether MasTec's current share price reflects its underlying worth, you are not alone. This article is built to help you weigh what you are really paying for. MasTec's share price recently closed at US$241.80, with returns of 7.8% over the last 30 days and 51.4% over the last year. These returns can change how investors think about both growth potential and risk. Recent headlines around MasTec have focused on its role as a large engineering and construction player in...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Valuation Check As New Flavor Launches Draw Fresh Customer And Investor Attention

Wingstop (WING) is back in the spotlight after rolling out two limited time flavor plays: a Lemon Pepper Schmear with PopUp Bagels ahead of the Big Game and a nationwide Hot Honey Trio across its restaurants. See our latest analysis for Wingstop. Those new flavor launches and brand partnerships come as Wingstop’s share price sits at US$271.39, with a 30 day share price return of 5.93% and a 90 day share price return of 6.44%. The 1 year total shareholder return of 2.59% contrasts with a 3...
NYSE:KTB
NYSE:KTBLuxury

How Lee’s First Beauty Collaboration With Goody At Kontoor Brands (KTB) Has Changed Its Investment Story

In January 2026, Goody announced a limited-edition collaboration with Kontoor Brands’ Lee, launching 20 Americana-inspired hairbrushes and accessories exclusively at Walmart, Walmart.com, and Lee.com, priced between US$5.94 and US$12.94. This marks Lee’s first move into the hair and beauty category, extending the denim label’s heritage into an adjacent, fashion-focused accessories space. Next, we’ll examine how Lee’s first hair and beauty collection with Goody may influence Kontoor Brands’...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Should NeoGenomics’ CFO Transition and Early 2025 Revenue Signals Require Action From NEO Investors?

NeoGenomics, Inc. announced in January 2026 that life sciences tools and diagnostics veteran Abhishek Jain joined as Executive Vice President and will succeed retiring CFO Jeff Sherman following completion of the company’s 2025 year-end audit, alongside preliminary 2025 revenue guidance indicating double-digit year-over-year growth. The combination of a planned CFO handover to an experienced industry finance leader and early visibility into revenue performance gives investors a clearer view...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

The Bull Case For Wintrust Financial (WTFC) Could Change Following Record Earnings And Dividend Hike – Learn Why

In January 2026, Wintrust Financial reported stronger fourth-quarter and full-year 2025 results, with higher net interest income, net income of US$223.02 million for the quarter, and earnings per share beating analyst expectations, while also approving a quarterly common dividend increase to US$0.55 per share and maintaining dividends on its 7.875% Series F preferred stock. An interesting angle for investors is how Wintrust combined record profitability and solid loan and deposit growth with...